Loading Events
  • This event has passed.

The PM Society is excited to launch its second Market Access Interest Group (MAIG) educational event.

Join us to learn more about the ever-changing Market Access Landscape and hear presentations from the leading UK bodies involved in access, latest best practices from industry and pharma initiatives, alongside results from recent landmark access surveys.

  • 12:30 pm

    Registration & refreshments

  • 1:00 pm

    Craig Bradley, Chairman, PM Society

  • 1:10 pm

    The Current Routes to Market Access through NICE
    Rufaro Kausi, HTA Adviser, Technology Appraisals, NICE

  • 1:40 pm

    The state of the access relationship between the NHS and life sciences sector
    Conor Burke, Strategic Advisor, Visions4Health (ex-chief exec of Barking, Dagenham and Havering CCG’s)

  • 1:55 pm

    Evolution of UK market access
    Mike Ringe, ABPI, NHS Engagement Partner, Specialised Commissioning & Rare Disease

  • 2:20 pm

    A report of the Round Table Discussion, “Overcoming Barriers to access for specialised medicines”
    Senior representatives from NHS England, clinical and finance leads, pharmacy, and patient groups
    Presented by Ivor Eisenstadt, Managing Director, MGP

  • 2:45 pm

    Question & Answers

  • 3:30 pm


  • 4:00 pm

    Implementing the NHS Long Term Plan
    Steve How, Programme Director, Wilmington

  • 4:25 pm

    Influencing local guidelines and formularies: data findings and real-world case study
    Jan Flynn, External Affairs at Rosemont and Karen Westaway, Chief Executive at ValueBase

  • 4:50 pm

    Breaking down market access barriers
    Dr Séamus O’Neill, Chief Executive Academic Health Science Network for the North East and North Cumbria Chair AHSN Network

  • 5:15 pm

    Question & Answers

  • 5:55 pm

    Wrap up

  • 6:00 pm

    Networking drinks

Event details

Thu 6th June 2019
12:30 pm - 5:00 pm


Royal Society Medicine
1 Wimpole Street
London, W1G 0AE United Kingdom